These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6341010)

  • 1. Comparison of plasma glucose and plasma free insulin during CSII and intensified conventional insulin therapy.
    Buysschaert M; Marchand E; Ketelslegers JM; Lambert AE
    Diabetes Care; 1983; 6(1):1-5. PubMed ID: 6341010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free insulin profiles during intensive treatment with biosynthetic human insulin.
    Olsson PO; Arnqvist HJ; Von Schenck HV
    Diabete Metab; 1988; 14(3):253-8. PubMed ID: 3044863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rarity of a marked "dawn phenomenon" in diabetic subjects treated by continuous subcutaneous insulin infusion.
    Bending JJ; Pickup JC; Collins AC; Keen H
    Diabetes Care; 1985; 8(1):28-33. PubMed ID: 3971844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose Level.
    Castillo MJ; Scheen AJ; Lefèbvre PJ
    J Clin Endocrinol Metab; 1996 May; 81(5):1975-8. PubMed ID: 8626867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overnight metabolic control with bedtime injection of intermediate-acting insulin or continuous subcutaneous insulin infusion.
    Olsson PO; Arnqvist H; Von Schenck H; Ottosson AM
    Diabetes Care; 1987; 10(6):702-6. PubMed ID: 3322726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on blood lipid and intermediary metabolite concentrations during conventional insulin treatment or CSII.
    Lawson P; Home PD; Bergenstal R
    Diabetes; 1985 Aug; 34 Suppl 3():27-30. PubMed ID: 3894126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise in insulin-dependent diabetes mellitus: the effect of continuous insulin infusion using the subcutaneous, intravenous, and intraperitoneal sites.
    Gooch BR; Abumrad NN; Robinson RP; Petrik M; Campbell D; Crofford OB
    Diabetes Care; 1983; 6(2):122-8. PubMed ID: 6343016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M; Lejeune M; Lambert AE
    Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early morning glycaemia and the metabolic consequences of delaying breakfast/morning insulin. A comparison of continuous subcutaneous insulin infusion and multiple injection therapy with human isophane or human ultralente insulin at bedtime in insulin-dependent diabetics.
    Haakens K; Hanssen KF; Dahl-Jørgensen K; Vaaler S; Torjesen P; Try K
    Scand J Clin Lab Invest; 1989 Nov; 49(7):653-9. PubMed ID: 2692136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.
    Attia N; Jones TW; Holcombe J; Tamborlane WV
    Diabetes Care; 1998 May; 21(5):817-21. PubMed ID: 9589247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion.
    Reeves ML; Seigler DE; Ryan EA; Skyler JS
    Am J Med; 1982 Apr; 72(4):673-80. PubMed ID: 7041646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
    Bi YF; Zhao LB; Li XY; Wang WQ; Sun SY; Chen YH; Hong J; Su TW; Liu JM; Ning G
    Chin Med J (Engl); 2007 Oct; 120(19):1700-3. PubMed ID: 17935674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of intensified insulin therapy: HbA1 versus blood glucose.
    Bischof F; Meyerhoff C; Pfeiffer EF
    Horm Metab Res; 1994 Dec; 26(12):574-8. PubMed ID: 7705761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on control of glycemia with conventional insulin therapy or continuous subcutaneous insulin infusion.
    Tamborlane WV; Champion MC; Rizza RA; Service FJ; Bergenstal RM
    Diabetes; 1985 Aug; 34 Suppl 3():22-6. PubMed ID: 3894125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapy.
    Bergenstal RM; Dupre J; Lawson PM; Rizza RA; Rubenstein AH
    Diabetes; 1985 Aug; 34 Suppl 3():31-6. PubMed ID: 3926568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemia and counterregulation in insulin-dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin injection therapy.
    Ng Tang Fui S; Pickup JC; Bending JJ; Collins AC; Keen H; Dalton N
    Diabetes Care; 1986; 9(3):221-7. PubMed ID: 3525052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nine years' personal experience of intensified diabetes control: infusion versus injections.
    Jarrett AM
    Diabet Med; 1986; 3(6):552-6. PubMed ID: 2951212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.